Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nalbuphine Allergy × Nalbuphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain, Postoperative 1 Neoplasms 1 Nalbuphine Allergy 1 Mouth Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Emergence Delirium 1 Chronic Pain 1 Breast Neoplasms 1

Interventions

Nalbuphine 1 Morphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05073744 2022-12-29

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Zhongda Hospital

Phase 4 Unknown

Nalbuphine Allergy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡